The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors
- PMID: 4042273
- DOI: 10.1093/carcin/6.10.1441
The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitors
Abstract
These experiments were designed to define the conditions necessary for the modification of radiation-induced transformation in C3H/10T1/2 cells by TPA and protease inhibitors. The results show that: (i) the lowest effective dose of various protease inhibitors to suppress transformation in vitro varies over several orders of magnitude; on a molar basis, the inhibitors of chymotrypsin appear to be the most effective protease inhibitors at suppression of radiation-induced transformation in vitro, (ii) the protease inhibitors antipain and the Bowman-Birk (soybean) protease inhibitor have no effect on radiation transformation when present only during irradiation, (iii) the protease inhibitor antipain can suppress radiation transformation in vitro when applied to proliferating "initiated' cells as late as 10 days and 13 cell divisions post-irradiation, and (iv) TPA treatment following a 10-day protease inhibitor (anti-pain) exposure of X-irradiated "initiated' cells does not lead to promotion in vitro. These results suggest that protease inhibitor treatment of the initiated cells has irreversibly reverted cells to their original or "uninitiated' condition which existed before irradiation.
Similar articles
-
DNA repair and malignant transformation: effect of X irradiation, 12-O-tetradecanoyl-phorbol-13-acetate, and protease inhibitors on transformation and sister-chromatid exchanges in mouse 10T 1/2 cells.Radiat Res. 1979 Aug;79(2):241-55. Radiat Res. 1979. PMID: 482597 No abstract available.
-
Effects of protease inhibitors on radiation transformation in vitro.Cancer Res. 1981 Jun;41(6):2103-8. Cancer Res. 1981. PMID: 7237415
-
Enhanced transformation of mouse 10T1/2 cells by 12-O-tetradecanoylphorbol-13-acetate following exposure to X-rays or to fission-spectrum neutrons.Cancer Res. 1982 Feb;42(2):477-83. Cancer Res. 1982. PMID: 7055800
-
Prevention of carcinogenesis by protease inhibitors.Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Cancer Res. 1994. PMID: 8137328 Review.
-
The induction and control of radiogenic transformation in vitro: cellular and molecular mechanisms.Pharmacol Ther. 1985;27(1):99-142. doi: 10.1016/0163-7258(85)90066-x. Pharmacol Ther. 1985. PMID: 3889941 Review. No abstract available.
Cited by
-
Is there a critical target gene for the first step in carcinogenesis?Environ Health Perspect. 1991 Jun;93:199-203. doi: 10.1289/ehp.9193199. Environ Health Perspect. 1991. PMID: 1773792 Free PMC article. Review.
-
A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3120-4. doi: 10.1073/pnas.89.7.3120. Proc Natl Acad Sci U S A. 1992. PMID: 1557421 Free PMC article.
-
A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.Proc Natl Acad Sci U S A. 1987 Jul;84(14):4801-5. doi: 10.1073/pnas.84.14.4801. Proc Natl Acad Sci U S A. 1987. PMID: 3299374 Free PMC article.
-
A serine protease-inhibitory benzamidine derivative inhibits the growth of human colon carcinoma cells.Jpn J Cancer Res. 1992 Jul;83(7):723-8. doi: 10.1111/j.1349-7006.1992.tb01972.x. Jpn J Cancer Res. 1992. PMID: 1517149 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources